Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.70+0.71 (+7.11%)
At close: 04:00PM EDT
10.70 0.00 (0.00%)
After hours: 07:38PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/21/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.48
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 349.66
52 Week Low 37.57
50-Day Moving Average 312.92
200-Day Moving Average 322.50

Share Statistics

Avg Vol (3 month) 3591.7k
Avg Vol (10 day) 31.19M
Shares Outstanding 564.44M
Implied Shares Outstanding 6N/A
Float 846.53M
% Held by Insiders 14.40%
% Held by Institutions 199.02%
Shares Short (Apr 28, 2022) 47.56M
Short Ratio (Apr 28, 2022) 415.96
Short % of Float (Apr 28, 2022) 416.70%
Short % of Shares Outstanding (Apr 28, 2022) 411.72%
Shares Short (prior month Mar 30, 2022) 48.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 04, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jan 04, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.10%
Return on Equity (ttm)-35.29%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -163.01M
Net Income Avi to Common (ttm)-169.07M
Diluted EPS (ttm)-3.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)388.74M
Total Cash Per Share (mrq)6.03
Total Debt (mrq)22.6M
Total Debt/Equity (mrq)4.97
Current Ratio (mrq)17.69
Book Value Per Share (mrq)7.54

Cash Flow Statement

Operating Cash Flow (ttm)-121.16M
Levered Free Cash Flow (ttm)-82.57M
Advertisement
Advertisement